Professional community engagement report

 

 

Identify a community that you know or belong to (e.g. a sports club, a church group, or perhaps one of the university clubs/societies). The community that you choose should be one that you can observe directly, and acquire information on without recourse to complex ethnographic methods. The purpose of this assignment is to undertake a professional needs assessment of your chosen community, and report the findings.

 

Step 1: Choose a community
Choose a community that is known to you, or one that is easily observable. Do NOT choose very large or scattered communities (such as the Indigenous People of Australia, the Christian Community, or the Cross Fit community) as this will affect your capacity to analyse them properly. Instead, pick a smaller group (such as an Indigenous association that you know of, a local Church community, or a local sporting club) that you can observe and come up with ideas for.

• Explain why the community interests you in a professional capacity.
• Explain why your chosen community is important, and what they offer both society and individuals.
• Describe the challenges faced by your chosen community and how they arose, supported by evidence (community mapping).
• Describe the goals of your chosen community based on your previous experience within that community, as well as conversations you might have had with community peers (see note on anonymising content below).
• Based on those challenges and the community’s goals, assess what the community’s needs might be, and explain how you would prioritise those needs.
• Identify and explain what skills you might need (as a member of that community) to maximise the success of achieving your chosen community’s goals.
• Include at least six appropriate references. At least three of these must be scholarly readings.

 

Sample Solution

Each cancer and tumor type is unique as is the individual in which it develops. Some cancers do not respond to established cancer treatments, such as chemotherapy or radiation therapy, because tumor cells have developed ways to evade the immune system by taking advantage of peripheral tolerance. Recent advances in immunotherapy have given rise to drastic advances in cancer treatment that allow targeted, tumor-cell-specific effects. These advances include immunomodulation checkpoint PD-1/PD-L1 and CTLA-4 inhibitors along with tumor associated antigen specific CAR-T-cell based therapies.

PD-1/PD-L1 based therapies use inhibitors that prevent the association of programmed death-ligand 1 (PD-L1) with its receptor programmed cell death protein 1 (PD-1) which are proteins present on the surface of specific cells. PD-1 is an immune checkpoint that prevents unwarranted immune responses to antigens and protects against autoimmunity. An immune checkpoint is a molecule on immune cells that needs to be activated to start an immune response. This allows for the body to discriminate between regular cells in the body (“self”) and foreign entities. When PD-1 expressed on T-cells encounters its ligands, its functional activities are reduced, including proliferation, cytokine secretion and cytolytic activity. This suppression of the immune system limits the killing of bystander host cells and prevents autoimmune disease.

This question has been answered.

Get Answer
WeCreativez WhatsApp Support
Our customer support team is here to answer your questions. Ask us anything!
👋 Hi, Welcome to Compliant Papers.